Schizophrenia is a chronic, severe, and disabling brain disorder that has affected people throughout history. It is characterized by hallucinations, delusions, and disorganized thinking and behavior. Symptoms may include talking to oneself, hearing voices, paranoia, and poor emotional control. People with schizophrenia often experience difficulties with daily activities, including work, school, and relationships. The cause of schizophrenia is unknown, but it is thought to involve a combination of environmental and genetic factors. It is believed to be related to a disruption in how the brain processes dopamine, a neurotransmitter involved in understanding and interpreting reality. Schizophrenia is also linked to abnormalities in brain structure and function, which can be seen in brain imaging scans, such as MRI. Treatment for schizophrenia is focused on controlling symptoms and improving quality of life. Common medications used for treatment include antipsychotic drugs like clozapine, risperidone, and olanzapine. These help to reduce hallucinations, delusions, and other symptoms. Therapy can also be used to help people cope with the social, emotional, and cognitive challenges of their disorder. Additionally, it is important for individuals to take an active role in managing their symptoms and recovery. Schizophrenia can be a difficult disorder to manage and treatment can often involve a multidisciplinary approach. It is important to remember that people with schizophrenia can still lead meaningful and productive lives with the proper support and treatment.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States